Seeing the Future Through Science
British website and journal Optometry Today recently published an article about the preliminary safety results from jCyte’s ongoing retinitis pigmentosa trial. The piece discussed the treatment’s safety […]
July 15, 2016 – Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report their […]
The Ophthalmologist has honored Dr. Henry Klassen as one of the 100 most influential people in ophthalmology. The second annual Ophthalmologist Power List notes Dr. Klassen’s longstanding efforts to […]
Vanna Belton was essentially blind for more than five years before an unconventional stem cell study helped her regain limited vision. But even the study’s […]
In two separate studies, researchers have used human cells reprogrammed to become stem cells to generate transplantable cornea tissue. The first study used the stem cell-generated tissue to repair corneas […]
The Stem Cellar, California Institute for Regenerative Medicine’s (CIRM’s) official blog, recently posted its top 10 stories from 2015. Not surprisingly, a story about jCyte ranked first. The story, CIRM-Funded UC-Irvine […]
I am pleased to give a quick update on the trial, which is going well. Four patients who have been severely affected by retinitis pigmentosa have […]
August 12, 2015 Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported […]
August 11, 2015 A clinical trial using stem cells to treat people who have lost their vision due to retinitis pigmentosa (RP) has treated its […]
July 28, 2015 A first-of-its-kind stem cell-based retinitis pigmentosa treatment developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent […]